India Government Procurement Preference Norms – Rising Local Flavour
Executive Summary
Increasing local content requirements have been stipulated in the public purchase preference norms for medicines in India. Backward-integrated Indian firms stand to gain but progressive localization requirements for drugs not made in India appear to be a tough ask.
You may also be interested in...
Dr Reddy’s Is Latest Player To Pivot To Trade Generics In India
Dr Reddy’s Laboratories says it will work closely with its channel partners to ensure availability of its products, after entering into the unbranded, trade generics business in India with the launch of a new dedicated division, ‘RGenX’.
New Window: India Extends Price Cap Exemption To Foreign Innovation
Innovative medicines developed abroad and patented and launched in India could be entitled to unfettered pricing for a five-year period under new norms announced in the country. Orphan drugs could also qualify for such exemption, much to the concern of healthcare activists.
Can Modicare Reshape India’s Health Care Paradigm?
India’s new government-funded health care program expects to expand access to treatment to more than 100 million families. Can it effectively deliver on its promise and also materially expand opportunities for hospitals and pharma?